Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis (Review)

Oncology Letters

Volumn 5, Issue 2, 2013, Pages 411-416

  Xu, Yinghua ^a   Xia, Xiaoping ^a   Pan, Hongming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Autophagy; Cancer; Metastasis; Microenvironment; Pathway

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACTIVATING TRANSCRIPTION FACTOR 4; ARGININE DEIMINASE; BECLIN 1; BORTEZOMIB; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEOXYGLUCOSE; DRONABINOL; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN KINASE B; SPHINGOMYELIN PHOSPHODIESTERASE; TETRASPANIN;

ANGIOGENESIS; ANOXIA; AUTOPHAGY; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL DEATH; CELL FATE; CELL SURVIVAL; COLORECTAL TUMOR; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; METASTASIS; NEOPLASM; REVIEW; STRESS; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

EID: 84871568701     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1015     Document Type: Review

References (84)

1. Klionsky DJ: Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8: 931-937, 2007.
2. Hippert MM, O'Toole PS and Thorburn A: Autophagy in cancer: good, bad, or both? Cancer Res 66: 9349-9351, 2006.
3. Høyer-Hansen M and Jäättelä M: Autophagy: an emerging target for cancer therapy. Autophagy 4: 574-580, 2008.
4. Chen N and Debnath J: Autophagy and tumorigenesis. FEBS Lett 584: 1427-1435, 2010.
5. Tsuchihara K, Fujii S and Esumi H: Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett 278: 130-138, 2009.
6. Bao XH, Naomoto Y, Hao HF, Watanabe N, Sakurama K, NomaK, et al: Autophagy: Can it become a potential therapeutic target? Int J Mol Med 25: 493-503, 2010.
7. Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5: 726-734, 2005.
8. Yang Z and Klionsky DJ: An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 335: 1-32, 2009.
9. Vousden KH and Ryan KM: p53 and metabolism. Nat Rev Cancer 9: 691-700, 2009.
10. Kenific CM, Thorburn A and Debnath J: Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol 22: 241-245, 2010.
11. Lum JJ, DeBerardinis RJ and Thompson CB: Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6: 439-448, 2005.
12. Apel A, Zentgraf H, Büchler MW and Herr I: Autophagy-A double-edged sword in oncology. Int J Cancer 125: 991-995, 2009.
13. Roy S and Debnath J: Autophagy and tumorigenesis. Semin Immunopathol 32: 383-396, 2010.
14. Brech A, Ahlquist T, Lothe RA and Stenmark H: Autophagy in tumour suppression and promotion. Mol Oncol 3: 366-375, 2009.
15. Wang RC and Levine B: Autophagy in cellular growth control. FEBS Lett 584: 1417-1426, 2010.
16. Altman BJ and Rathmell JC: Autophagy: not good OR bad, but good AND bad. Autophagy 5: 569-570, 2009.
17. Rosenfeldt MT and Ryan KM: The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 11: e36, 2009.
18. Kroemer G, Mariño G and Levine B: Autophagy and the integrated stress response. Mol Cell 40: 280-293, 2010.
19. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64, 2006.
20. 2 availability on human cancer. Nat Rev Cancer 8: 967-975, 2008.
21. Mazure NM and Pouysségur J: Hypoxia-induced autophagy: cell death or cell survival. Curr Opin Cell Biol 22: 177-180, 2010.
22. Mazure NM and Pouysségur J: Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia. Autophagy 5: 868-869, 2009.
23. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, PrchalJT, Chen M and Wang J: Essential role for Nix in autophagic maturation of erythroid cells. Nature 454: 232-235, 2008.
24. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-MenezesD, Chiavarina B, Zhou J, et al: Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle 9: 3515-3533, 2010.
25. Srinivas V, Bohensky J, Zahm AM and Shapiro IM: Autophagy in mineralizing tissues: microenvironmental perspectives. Cell Cycle 8: 391-393, 2009.
26. Li X and Fan Z: The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 70: 5942-5952, 2010.
27. Rouschop KM and Wouters BG: Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr Mol Med 9: 417-424, 2009.
28. Pouysségur J, Dayan F and Mazure NM: Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443, 2006.
29. Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, AtomiY, et al: Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 67: 9677-9684, 2007.
30. Moreau K, Luo S and Rubinsztein DC: Cytoprotective roles for autophagy. Curr Opin Cell Biol 22: 206-211, 2010.
31. Jin S and White E: Role of autophagy in cancer: management of metabolic stress. Autophagy 3: 28-31, 2007.
32. Eng CH and Abraham RT: Glutaminolysis yields a metabolic by-product that stimulates autophagy. Autophagy 6: 968-970, 2010.
33. Marambio P, Toro B, Sanhueza C, Troncoso R, Parra V, VerdejoH, et al: Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim Biophys Acta 1802: 509-518, 2010.
34. Neufeld TP: TOR-dependent control of autophagy: biting the hand that feeds. Curr Opin Cell Biol 22: 157-168, 2010.
35. Lum JJ, DeBerardinis RJ and Thompson CB: Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6: 439-448, 2005.
36. N'Diaye EN, Debnath J and Brown EJ: Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy 5: 573-575, 2009.
37. Liao XH, Majithia A, Huang X and Kimmel AR: Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism. Amino Acids 35: 761-770, 2008.
38. Kumar SH and Rangarajan A: Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol 83: 8565-8574, 2009.
39. Hardie DG: AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785, 2007.
40. Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, LoughranP, et al: The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 17: 666-676, 2010.
41. Miranti CK and Brugge JS: Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-E90, 2002.
42. Gilmore AP: Anoikis. Cell Death Differ 12 (Suppl 2): 1473-1477, 2005.
43. Debnath J: Detachment-induced autophagy during anoikis and lumen formation in epithelial acini. Autophagy 4: 351-353, 2008.
44. Lock R and Debnath J: Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 20: 583-588, 2008.
45. Tuloup-Minguez V, Greffard A, Codogno P and Botti J: Regulation of autophagy by extracellular matrix glycoproteins in HeLa cells. Autophagy 77: 27-39, 2011.
46. Debnath J, Mills KR, Collins NL, Reginato MJ, MuthuswamySK and Brugge JS: The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29-40, 2002.
47. Inagi R: Endoplasmic reticulum stress as a progression factor for kidney injury. Curr Opin Pharmacol 10: 156-165, 2010.
48. Kaushik S, Singh R and Cuervo AM: Autophagic pathways and metabolic stress. Diabetes Obes Metab 12: 4-14, 2010.
49. Verfaillie T, Salazar M, Velasco G and Agostinis P: Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. Int J Cell Biol 17: 9305-9309, 2010.
50. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, KanemotoS, et al: Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26: 9220-9231, 2006.
51. Rzymski T, Milani M, Pike L, Buffa F, Mellor HR, WinchesterL, et al: Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 29: 4424-4435, 2010.
52. Yang PM, Liu YL, Lin YC, Shun CT, Wu MS and Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res 70: 7699-7709, 2010.
53. Ishida Y and Nagata K: Autophagy eliminates a specific species of misfolded procollagen and plays a protective role in cell survival against ER stress. Autophagy 5: 1217-1219, 2009.
54. Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente M, Egia A, et al: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119: 1359-1372, 2009.
55. Kim KW, Moretti L, Mitchell LR, Jung DK and Lu B: Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells. Oncogene 29: 3241-3251, 2010.
56. Qin L, Wang Z, Tao L and Wang Y: ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 6: 239-247, 2010.
57. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, KojimaM, et al: Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99: 1813-1819, 2008.
58. Wan XB, Fan XJ, Chen MY, Xiang J, Huang PY, Guo L, et al: Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 6: 395-404, 2010.
59. Giatromanolaki A, Koukourakis MI, Harris AL, PolychronidisA, Gatter KC and Sivridis E: Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 63: 867-872, 2010.
60. Bartholomeusz C, Rosen D, Wei C, Kazansky A, Yamasaki F, Takahashi T, et al: PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res 68: 9302-9310, 2008.
61. Miao Y, Zhang Y, Chen Y, Chen L and Wang F: GABARAP is overexpressed in colorectal carcinoma and correlates with shortened patient survival. Hepatogastroenterology 57: 257-261, 2010.
62. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, et al: The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 5: 303-306, 2009.
63. Nicotra G, Mercalli F, Peracchio C, Castino R, Follo C, ValenteG and Isidoro C: Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 23: 937-950, 2010.
64. Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, MourmourasV, et al: Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41: 503-512, 2010.
65. Won KY, Kim GY, Kim YW, Song JY and Lim SJ: Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol 41: 107-112, 2010.
66. Duan ZL, Peng ZL and Wang ZH: Expression and involved signal transduction pathway of autophagy gene Beclin 1 in epithelial ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 38: 239-242, 2007 (In Chinese).
67. Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, MarsiliS, et al: The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 5: 930-936, 2009.
68. Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, et al: Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 68: 9167-9175, 2008.
69. Huang JJ, Li HR, Huang Y, Jiang WQ, Xu RH, Huang HQ, et al: Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy 6: 777-783, 2010.
70. Mizushima N, Yoshimori T and Levine B: Methods in mammalian autophagy research. Cell 140: 313-326, 2010.
71. Smith EL and Schuchman EH: Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol Ther 16: 1565-1571, 2008.
72. Wei S, Kulp SK and Chen CS: Energy restriction as an antitumor target of thiazolidinediones. J Biol Chem 285: 9780-9791, 2010.
73. Zismanov V, Lishner M, Tartakover-Matalon S, Radnay J, ShapiroH and Drucker L: Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signaling. Br J Cancer 101: 1402-1409, 2009.
74. Fels DR, Ye J, Segan AT, Kridel SJ, Spiotto M, Olson M, et al: Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res 68: 9323-9330, 2008.
75. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinisRJ, Zhao F, et al: Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67: 6745-6752, 2007.
76. Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, GounonP, et al: Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 70: 2465-2475, 2010.
77. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, JungJU, et al: Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 69: 700-708, 2009.
78. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
79. Zhu K, Dunner K Jr and McConkey DJ: Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29: 451-462, 2010.
80. Dalby KN, Tekedereli I, Lopez-Berestein G and Ozpolat B: Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6: 322-329, 2010.
81. White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-5316, 2009.
82. Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z and Oren M: p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci USA 107: 18511-18516, 2010.
83. Chouaib S, Kieda C, Benlalam H, Noman MZ, Mami-Chouaib F and Rüegg C: Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit Rev Immunol 30: 529-545, 2010.
84. McPhee CK, Logan MA, Freeman MR and Baehrecke EH: Activation of autophagy during cell death requires the engulfment receptor Draper. Nature 465: 1093-1096, 2010.